Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily, has been considered to be a potential cancer therapeutic agent due to its ability to preferentially induce apoptosis in malignant cells but not in most normal cells [6]. This evidence concerns the gene TNFSF10 and cancer.